Evaluation of NWRD09 for HPV-16 Related Cervical HSIL

Clinical trial NCT07712692 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07712692
Sponsor: Newish Biotech (Wuxi) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High-grade Squamous Intraepithelial Lesion (HSIL)

Start date: 2026-08-01
Primary completion: 2027-06-30
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.